文献速递主动脉疾病

18F-FDG PET/MRI评估无症状腹主动脉瘤炎症的可行性

Feasibility of Assessing Inflammation in Asymptomatic Abdominal Aortic Aneurysms With Integrated 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2019-11-08

本研究对15例无症状肾下腹主动脉瘤(直径>45 mm)患者行FDG PET/MRI,评估主动脉壁炎症。结论认为FDG PET/MRI可用于研究无症状AAA炎症,但FDG热点与MRI炎症表现对应率低。

要点

  • FDG PET/MRI可用于评估无症状AAA的瘤壁炎症。
  • FDG热点数量与近期AAA增长相关。
  • LGE阳性者近期AAA扩张率更高。

核心结论

  • 全整合FDG PET/MRI可用于研究无症状腹主动脉瘤的炎症。
  • 瘤壁FDG不均匀摄取提示葡萄糖代谢增高,可能反映持续炎症。
  • FDG热点与MRI炎症表现对应率低,提示热点区域细胞活动类型待明确。
  • LGE和FDG热点均与近期动脉瘤增长相关,作为临床生长标志物需进一步研究。

研究设计与样本

  • 对15例无症状肾下腹主动脉瘤(直径>45 mm)患者行FDG PET/MRI。
  • 在肾上主动脉、非动脉瘤主动脉颈和动脉瘤三个水平评估FDG摄取及MRI炎症改变(水肿、壁增厚、晚期钆增强)。

主要发现

  • 动脉瘤壁FDG SUVmax为2.5,高于血池SUVmax 1.0(p < .001)。
  • 肾上主动脉最大靶本比(3.1 ± 0.6)和主动脉颈(2.7 ± 0.5)高于动脉瘤主动脉(2.5 ± 0.5;p < .001)。
  • 13例患者动脉瘤壁共观察到36个FDG热点。
  • 8例患者检出壁增厚和LGE。
  • FDG热点数量与近期AAA增长相关(r = 0.62,p = .01)。

临床怎么用

  • FDG PET/MRI可作为研究工具评估无症状AAA瘤壁炎症 activity。
  • FDG热点和LGE可能提示AAA近期增长风险,但尚不能作为临床常规标志物。

局限性

  • 样本量小(15例),结论需更大样本验证。
  • FDG热点与MRI炎症表现对应率低,其细胞学意义不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to evaluate the feasibility of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) combined with contrast enhanced magnetic resonance imaging (MRI) to identify inflammation in asymptomatic abdominal aortic aneurysms (AAA). METHODS: FDG PET/MRI was performed on 15 patients with asymptomatic infrarenal AAAs >45 mm diameter. Prevalence of FDG uptake and MRI findings of inflammatory changes (oedema, wall thickening, and late gadolinium enhancement [LGE]) in the aortic wall were investigated at three levels: suprarenal aorta; non-aneurysmal aortic neck; and AAA. RESULTS: The median diameter of the AAAs was 54 mm (range 47-65 mm) and the median expansion rate in the last 12 months was 3 mm (range 1-13 mm). The standard uptake value (SUV) of FDG in the aneurysmal wall (SUVmax 2.5) was higher than the blood pool (SUVmax 1.0; p < .001). The maximum target to background ratio was higher in the suprarenal aorta (mean ± SD; 3.1 ± 0.6) and aortic neck (2.7 ± 0.5) than in the aneurysmal aorta (2.5 ± 0.5; p < .001). Thirty-six FDG hotspots were observed in the aneurysmal wall of 13 patients. Wall thickening and LGE were identified in eight patients. The number of FDG hotspots correlated with recent AAA growth (r = 0.62, p = .01). The recent aneurysm expansion rate was higher in aneurysms with LGE than in those without (7 mm vs. 2 mm; p = .03). MRI inflammatory changes were observed in nine of 36 hot spots (25%) and in three of 13 patients with focal FDG uptake. CONCLUSION: Fully integrated FDG PET/MRI can be used to study inflammation in asymptomatic AAAs. Heterogenous uptake of FDG in the aneurysmal wall indicates increased glucose metabolism, suggesting an ongoing inflammation. However, these FDG hotspots rarely correspond to MRI findings of inflammation, raising the question of which type of cellular activity is present in these areas. The presence of LGE and FDG hotspots both correlated to recent aneurysm growth, and their usefulness as clinical markers of aneurysm growth warrant additional investigation.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kuzniar M, Tegler G, Wanhainen A, et al. Feasibility of Assessing Inflammation in Asymptomatic Abdominal Aortic Aneurysms With Integrated 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging. Eur J Vasc Endovasc Surg. 2019. PMID: 31708339. doi:10.1016/j.ejvs.2019.04.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。